这种菌株通过VEGFR-2促进三阴性乳腺癌的扩散和迁移
Shalarria Cooper1, Molly Matthews1, Michael Knight2
1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294 USA.
Cellular and molecular bioengineering
|November 4, 2025
概括
瘤微环境中的机械应变推动了三阴性乳腺癌 (TNBC) 的进展. 阻断VEGFR-2 (血管内皮生长因子受体2) 抑制了这种由菌株引起的迁移和增殖,提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 生物物理学的生物物理.
- 癌症生物学 癌症生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 的预后比其他乳腺癌亚型更差.
- 在瘤微环境 (TME) 中,与癌症相关的纤维细胞 (CAF) 影响TNBC的进展.
- 在TNBC上的VEGFR-2 (血管内皮生长因子受体2) 表达与生存率降低相关,而机械菌株激活VEGFR-2以促进血管生成.
研究的目的:
- 为了研究TNBC细胞上的VEGFR-2可以被机械激活的假设.
- 为了确定VEGFR-2的机械激活是否会改变TNBC的迁移和增殖.
- 在TME模型中探索机械应变和VEGFR-2在TNBC进展中的作用.
主要方法:
- 使用MDA-MB-231 TNBC细胞,CAF和正常乳腺纤维细胞 (NBF) 建立了一个多微组织TME模型.
- 在没有生长因子的情况下,使用磁珠来施加机械应变.
- 量化了TNBC迁移和扩散 (通过Ki67染色评估).
主要成果:
- 与NBF相比,TNBC细胞向CAF迁移显著增加 (5x).
- 在TME模型中,单纯的机械应变使TNBC迁移增加了2倍.
- 抑制VEGFR-2降低了TNBC的总体迁移和扩散,即使在机械应变下.
结论:
- 在TME内的机械应变显著增强了TNBC的迁移和扩散.
- 在介导机械应变对TNBC的影响方面,VEGFR-2起着至关重要的作用.
- 通过VEGFR-2准机械信号,为TNBC提供了潜在的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


